DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Gamulescu MA, Framme C, Sachs H.
RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD.
Graefes Arch Clin Exp Ophthalmol 2007;
245: 1037-1040
We do not assume any responsibility for the contents of the web pages of other providers.